Impairment and restoration of nitric oxide-dependent vasodilation in cardiovascular disease

International Journal of Cardiology

Volumn 62, Issue SUPPL. 2, 1997, Pages

  Lyons, Declan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Diabetes; Endothelium; Hyperlipidaemia; Hypertension; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ASCORBIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FISH OIL; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PLACEBO; QUINAPRIL;

AGING; ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031593127     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00247-7     Document Type: Conference Paper

References (63)

1. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
2. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
3. Nishida K., Harrison D.G., Navas J.P., Fisher M., Dockery S.P., Uematsu M. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 90:1992;2092-2096.
4. Weiner C.P., Lizasoain L., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
5. Rapoport R.M., Draznin M.B., Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature. 306:1983;174-176.
6. Radomski M.W., Palmer R.M., Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA. 87:1990;5193-5197.
7. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 89:1992;7674-7677.
8. Wennmalm A., Benthen G., Edlund A.et al. Metabolism and excretion of nitric oxide in humans: An experimental and clinical study. Circ Res. 73:1993;1121-1127.
9. Radomski M.W., Palmer R.M., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. ii:1987;1057-1058.
10. Radomski M.W., Palmer R.M., Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 92:1987;639-646.
11. Cohen R.A., Shepherd J.T., Vanhoutte P.M. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 221:1983;273-274.
12. Yang Z., Stulz P., Von S.L., Bauer E., Turina M., Luscher T.F. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet. 337:1991;939-943.
13. 2. Circulation. 89:1994;2266-2272.
14. De Mey J.G., Claeys M., Vanhoutte P.M. Endothelium-dependent inhibitory effects of acetylcholine, adenosine diphosphate, thrombin and arachidonic acid in the canine femoral artery. J Pharmacol Exp Ther. 222:1982;166-173.
15. Forstermann U., Closs E.I., Pollock J.S., Nakane M., Schwarz P., Gath L. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions. Hypertension. 23:1994;1121-1131.
16. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities. Biol Chem Hoppe Seyler. 376:1995;327-343.
17. Julou-Schaeffer G., Gray G.A., Fleming L., Schott C., Parratt J.R., Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol. 259:1990;1038-1043.
18. Dubey R.K., Jackson E.K., Luscher T.F. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic nucleotides and angiotensin-I receptors. J Clin Invest. 96:1995;141-149.
19. Palmer R.M.J., Rees D.D., Ashton D.S., Moncada S. L L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation. Biochem Biophys Res Commun. 153:1988;1251-1256.
20. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281.
21. Gardiner S.M., Kemp P.A., Bennett T., Palmer R.M., Moncada S. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur J Pharmacol. 213:1992;449-451.
22. Vallance P., Collier J., Moncada S. Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet. ii:1989;997-1000.
23. Haynes W.G., Noon J.P., Walker B.R., Webb D.J. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 11:1993;1375-1380.
24. Lyons D., Roy S., Patel M., Benjamin N., Swift C.G. Impaired nitric oxide mediated vasodilation and total body nitric oxide production in old age. Clin Sci. 93:1997;519-525.
25. Moreau P., Takase H., Kung C.F., van Rouijen M.M., Schaffner T., Luscher T.F. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke. 26:1995;1922-1929.
26. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. Hypertension. 10:1992;1025-1031.
27. Vane J.R., Änggård E.E., Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
28. Whittle B.J.R., Lopez-Belmonte J., Rees D.D. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol. 98:1989;646-652.
29. Shimokawa H., Lam J.Y.T., Chesebro J.H., Bowie E.J.W., Vanhoutte P.M. Effects of dietary supplementation with cod liver oil on endothelium-dependent responses in porcine coronary arteries. Circulation. 76:1987;898-908.
30. Sugimoto T., Tobian L., Ganguli M.C. High potassium diet protects against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats. Hypertension. 11:1988;579-585.
31. Luscher T.F., Raij L., Vanhoutte P.M. Effect of hypertension and its reversal on endothelium dependent relaxations in the aorta of the rat. J Hypertens. 5:1987;153-155.
32. Luscher T.F., Vanhoutte P.M., Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 9:1987;193-197.
33. Panza J.A., Arshed A.Q., Callahan T.S., Epstein S.E. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 21:1993;1145-1151.
34. Creager M.A., Roddy M.A. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 24:1994;499-505.
35. Cockcroft J.R., Benjamin N., Chowienczyk P.J., Ritter J.M. Preserved endothelium dependent vasodilatation in patients with essential hypertension. N Engl J Med. 330:1994;1036-1040.
36. G-monomethyl-L-arginine in patients with essential hypertension. J Hypertension. 12:1994;1047-1052.
37. Chowienczyk P.J., Watts G.F., Cockcroft J.R., Ritter J.M. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 340:1992;1430-1432.
38. Randall M.D., Ujiie H., Griffith T.M. L L-Arginine reverses the impairment of nitric oxide-dependent collateral perfusion in dietary-induced hypercholesterolaemia in the rabbit. Clin Sci Colch. 87:1994;53-59.
39. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
40. Treasure C.B., Klein J.L., Weintraub W.S., Talley J.D., Stillabower M.E., Kosinski A.S. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
41. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
42. Mancini G.B.J., Henry G.C., Macaya C., O'Neill B.J., Pucillo A.L., Carere R.G. Angiotensin converting enzyme inhibition with quinapril improves vasomotor dysfunction in patients with coronary artery disease: TREND study. Circulation. 94:1996;258-265.
43. Messent J.W.C., Elliott T.G., Hill R.D., Jarrett R.J., Keen H., Viberti G. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 41:1992;836-839.
44. Viberti G.C., Jarrett R.J., Mahmud U., Hill R.D., Argyropoulos A., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. i:1982;1430-1432.
45. Calver A., Collier J., Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 90:1992;2548-2554.
46. Elliott T.G., Cockcroft J.R., Groop P.H., Viberti G.C., Ritter J.M. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci. 85:1993;687-693.
47. Kreye VAW. Sodium nitroprusside. In: Scriabine A, editor. Pharmacology of antihypertensive drugs. New York: Raven Press 1997: 373-96.
48. Halkin A., Benjamin N., Doktor H.S., Todd S.D., Viberti G.C., Ritter J.M. Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci. 81:1991;223-232.
49. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
50. McVeigh G.E., Brennan G.M., Johnston G.D. Impaired endothelium-dependent and independent vasodilation in patients with type II (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:1992;771-776.
51. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 27:1996;567-574.
52. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 97:1996;22-28.
53. Hongo K., Nakagomi T., Kassel N.F.et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 19:1988;892-897.
54. Winquist R.J., Bunting P.B., Baskin E.P., Wallace A.A. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J Hypertens. 2:1984;536-541.
55. Kung C.F., Luscher T.F. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 25:1995;194-200.
56. Vita J.A., Treasure C.B., Nabel E.G.et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
57. Yasue H., Matsuyama K., Matsuyama K., Okumura K., Morikami Y., Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation. 81:1990;482-490.
58. Egashira K., Inou T., Hirooka Y.et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation. 88:1993;77-81.
59. Zeiher A.M., Drexter H., Saurbier B., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 92:1993;652-662.
60. Taddei S., Virdis A., Mattei P.et al. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation. 91:1995;1981-1987.
61. Mayhan W.G., Faraci F.M., Baumbach G.L., Heistad D.D. Effects of aging on responses of cerebral arterioles. Am J Physiol. 258:1990;1138-1143.
62. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium dependent vasodilation in experimental diabetes. J Clin Invest. 87:1991;432-438.
63. Kung C.F., Luscher T.F. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension. 25:1995;194-200.